July 25, 2017 7:54 AM ET

Healthcare Providers and Services

Company Overview of ProPharma Group, Inc.

Executive Profile

Gil Price M.D.

Chief Medical Officer, ProPharma Group, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 5 different industries.

See Board Relationships
61--

Background

Dr. Gil Price, M.D., has been Chief Medical Officer of ProPharma Group, Inc. since June 5, 2017. Before joining ProPharma Group, Dr. Price served as the Chief Executive Officer and Chief Medical Officer at Drug Safety Solutions, recently acquired by ProPharma Group since 2002. He served as a Strategic Advisor of Advanced Clinical Research Services, LLC. Dr. Price served as a Medical Advisor and Medical Monitor of Accelovance, Inc. He is a Founding executive of three ...

Corporate Headquarters

8717 West 110th Street
Overland Park, Kansas 66210

United States

Phone: 913-661-1662
Fax: 913-663-2729

Board Members Memberships

There is no Board Members Memberships data available.

Education

Unknown/Other Education
University of Cambridge
MD
Universidad de Santiago de Chile
BS
Universidade do Grande Rio

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ProPharma Group, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.